MedEase Anesthesia: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MedEase Anesthesia
Largest movements
- Cash +€131,692
up €131,692 (+100.2%), from €131,366 to €263,058
mainly Other debts (+€167,000) and Net result for the year (+€151,631)
- Receivables within one year +€4,180
up €4,180 (+72.7%), from €5,754 to €9,934
of which Other amounts receivable: +€3,680
- Deferred charges and accrued income -€4,124
down €4,124 (-11.7%), from €35,231 to €31,107
- Other debts +€167,000
up €167,000 (+668.0%), from €25,000 to €192,000
- Profit (loss) carried forward -€88,369
down €88,369 (-91.9%), from €96,204 to €7,835
- Tax, wage and social debts +€49,370
up €49,370 (+90.1%), from €54,805 to €104,175
- Gross operating margin +€67,541
up €67,541 (+50.1%), from €134,813 to €202,353
- Taxes +€18,070
up €18,070 (+62.0%), from €29,153 to €47,223
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €179,271 | €310,103 | +€130,832 | +73.0% |
| Fixed assets | 21/28 | €6,919 | €6,004 | -€916 | -13.2% |
| Tangible fixed assets | 22/27 | €6,919 | €6,004 | -€916 | -13.2% |
| Furniture and vehicles | 24 | €6,919 | €6,004 | -€916 | -13.2% |
| Current assets | 29/58 | €172,351 | €304,099 | +€131,748 | +76.4% |
| Amounts receivable within one year | 40/41 | €5,754 | €9,934 | +€4,180 | +72.7% |
| Trade receivables | 40 | - | €500 | +€500 | |
| Other amounts receivable | 41 | €5,754 | €9,434 | +€3,680 | +64.0% |
| Cash at bank and in hand | 54/58 | €131,366 | €263,058 | +€131,692 | +100.2% |
| Deferred charges and accrued income | 490/1 | €35,231 | €31,107 | -€4,124 | -11.7% |
| Total equity and liabilities | 10/49 | €179,271 | €310,103 | +€130,832 | +73.0% |
| Equity | 10/15 | €98,704 | €10,335 | -€88,369 | -89.5% |
| Contributions | 10/11 | €2,500 | €2,500 | = | 0.0% |
| Profit (loss) carried forward | 14 | €96,204 | €7,835 | -€88,369 | -91.9% |
| Amounts payable | 17/49 | €80,566 | €299,768 | +€219,202 | +272.1% |
| Amounts payable within one year | 42/48 | €80,566 | €299,587 | +€219,020 | +271.9% |
| Trade debts | 44 | €761 | €3,411 | +€2,650 | +348.0% |
| Suppliers | 440/4 | €761 | €3,411 | +€2,650 | +348.0% |
| Taxes, remuneration and social security | 45 | €54,805 | €104,175 | +€49,370 | +90.1% |
| Taxes | 450/3 | €54,805 | €104,175 | +€49,370 | +90.1% |
| Other amounts payable | 47/48 | €25,000 | €192,000 | +€167,000 | +668.0% |
| Accrued charges and deferred income | 492/3 | - | €181 | +€181 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €873 | €2,287 | +€1,414 | +161.9% |
| Other operating charges | 640/8 | - | €332 | +€332 | |
| Gross operating margin | 9900 | €134,813 | €202,353 | +€67,541 | +50.1% |
| Operating profit (loss) | 9901 | €133,940 | €199,735 | +€65,795 | +49.1% |
| Financial income | 75/76B | - | €5 | +€5 | |
| Recurring financial income | 75 | - | €5 | +€5 | |
| Financial charges | 65/66B | €47 | €887 | +€839 | +1769.1% |
| Recurring financial charges | 65 | €47 | €887 | +€839 | +1769.1% |
| Profit (loss) for the period before taxes | 9903 | €133,892 | €198,854 | +€64,961 | +48.5% |
| Income taxes | 67/77 | €29,153 | €47,223 | +€18,070 | +62.0% |
| Profit (loss) for the period | 9904 | €104,740 | €151,631 | +€46,891 | +44.8% |
| Profit (loss) for the period to be appropriated | 9905 | €104,740 | €151,631 | +€46,891 | +44.8% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 12 October 2026 via checked.be.